Main|Search|PHGKB

J Clin Lab Anal. 2018 Jul 25:e22630. doi: 10.1002/jcla.22630. [Epub ahead of print]

Detection of copy number variants using chromosomal microarray analysis for the prenatal diagnosis of congenital heart defects with normal karyotype.

Song T1, Wan S1, Li Y1, Xu Y1, Dang Y1, Zheng Y1, Li C1, Zheng J1, Chen B1, Zhang J1.

Author information

Abstract

BACKGROUND:

With the increasing availability of chromosomal microarray analysis (CMA) for congenital heart defect (CHD), genetic testing now faces new challenges due to results with uncertain clinical impact. Studies are needed to better define the penetrance of genetic variants. The aim of the study was to examine the association between CMA and CHDs in fetuses with normal karyotype.

METHODS:

This was a retrospective study of 190 fetuses with normal karyotype that underwent CMA after a diagnosis of CHD by fetal ultrasound. Invasive prenatal diagnosis was performed between January 2015 and December 2016 at the first affiliated hospital of Air Force Medical University.

RESULTS:

Chromosomal microarray analysis detected pathogenic copy number variants (pCNVs) in 13/190 (6.84%) fetuses, likely pCNVs in 5/190 (2.63%), and variants of unknown significance (VOUS) in 14/190 (7.37%). Among those with pCNVs, none (0%) yielded a normal live birth. Among those with likely pCNVs, 2/5 (40.0%) yielded a live birth. Among the fetuses with VOUS, 10/14 (71.5%) yielded a live birth.

CONCLUSION:

These results highlight the usefulness of CMA for prenatal genetic diagnosis of fetuses with CHDs and normal karyotype. In fetuses with CHD, the application of CMA could increase the detection rate of pCNVs causing CHDs. In this study, some VOUS were likely pathogenic, but additional studies are necessary to confirm these findings.

© 2018 Wiley Periodicals, Inc.

KEYWORDS:

chromosomal microarray analysis; congenital heart defects; prenatal diagnosis; variants of unknown significance

PMID:

 

30047171

 

DOI:

 

10.1002/jcla.22630

Last Posted: Aug 02, 2018

---

• Detection of copy number variants using chromosomal microarray analysis for the prenatal diagnosis of congenital heart defects with normal karyotype.
  Song Tingting et al. Journal of clinical laboratory analysis 2018 Jul e22630
• Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations.
  Sen Ethan S et al. Journal of medical genetics 2017 Dec 54(12) 795-804
• Clinical Application of Chromosome Microarray Analysis in Han Chinese Children with Neurodevelopmental Disorders.
  Xu Mingyu et al. Neuroscience bulletin 2018 Jun
• Enrichment of Rare Copy Number Variation in Children with Developmental Language Disorder.
  Kalnak N et al. Clinical genetics 2018 May
• Reporting incidental findings of genomic disorder-associated copy number variants to unselected biobank participants.
  Leitsalu Liis et al. Personalized medicine 2016 Jul 13(4) 303-314
• Comprehensive genetic testing for female and male infertility using next-generation sequencing.
  Patel Bonny et al. Journal of assisted reproduction and genetics 2018 May
• The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.
  Hooper Amanda J et al. Current atherosclerosis reports 2018 May 20(6) 31
• Genetic generalized epilepsies.
  Mullen Saul A et al. Epilepsia 2018 May
• Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.
  Punj Sumit et al. American journal of human genetics 2018 May
• Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification.
  Hogan Gregory J et al. Clinical chemistry 2018 May

more